Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
41
NVAX Quote, Financials, Valuation and Earnings
Last price:
$6.86
Seasonality move
:
8.25%
Day range:
$6.74 - $6.90
52-week range:
$5.01 - $11.55
Dividend yield:
0%
P/E ratio:
3.84x
P/S ratio:
1.08x
P/B ratio:
32.13x
Volume:
2.7M
Avg. volume:
3.7M
1-year change:
-21.3%
Market cap:
$1.1B
Revenue:
$682.2M
EPS (TTM):
$1.77
Novavax, Inc. Number of Institutional Trades
Novavax, Inc. Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$400.3M
(Last 6 Months)
Current Institutional Ownership Percentage
92.72%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$306.1M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Novavax, Inc. Institutional Ownership
-
What Percentage Of NVAX Is Owned by Institutions?
92.72% of NVAX is owned by institutions.
-
How Many Institutions Own NVAX Shares?
Novavax, Inc. stock is owned by 458 institutional shareholders at this time.
-
Have Institutions Been Buying NVAX Stock?
Yes, institutions have bought 0 shares of NVAX in the last quarter.
-
Have Institutions Been Selling NVAX Stock?
Yes, institutions have sold 0 shares of NVAX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 2.7% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.32% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.75% over the past day.
